Scandinavian ChemoTech AB (publ)

Stockholm Stock Exchange CMOTEC-B.ST

Scandinavian ChemoTech AB (publ) EBIT Margin for the year ending December 31, 2023: -697.66%

Scandinavian ChemoTech AB (publ) EBIT Margin is -697.66% for the year ending December 31, 2023, a 84.17% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Scandinavian ChemoTech AB (publ) EBIT Margin for the year ending December 31, 2022 was -4,407.82%, a 87.35% change year over year.
  • Scandinavian ChemoTech AB (publ) EBIT Margin for the year ending December 31, 2021 was -34,832.65%, a -321.38% change year over year.
  • Scandinavian ChemoTech AB (publ) EBIT Margin for the year ending December 31, 2020 was -8,266.41%, a -280.95% change year over year.
  • Scandinavian ChemoTech AB (publ) EBIT Margin for the year ending December 31, 2019 was -2,169.96%, a -50.32% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: CMOTEC-B.ST

Scandinavian ChemoTech AB (publ)

CEO Mr. Stefan Mohan Frick
IPO Date Dec. 6, 2016
Location Sweden
Headquarters Medicon Village
Employees 6
Sector Healthcare
Industries
Description

Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. The company markets its products through distribution channels and a network of opinion leaders in South East Asia, India, and the Philippines. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.

Similar companies

CANTA.ST

Cantargia AB (publ)

USD 0.16

-4.29%

ERMA.ST

Enorama Pharma AB (publ)

USD 0.20

-7.01%

VICO.ST

Vicore Pharma Holding AB (publ)

USD 0.79

-2.96%

ALZ.ST

Alzinova AB (publ)

USD 0.25

-3.82%

StockViz Staff

February 5, 2025

Any question? Send us an email